
Loading, please wait...

Loading, please wait...

The champion paradox refers to a phenomenon where leaders who drive successful implementation might inadvertently undermine long-term sustainability. While champions provide the enthusiasm needed to launch programs, their presence can create systemic vulnerabilities over time. Consequently, a recent multiple case study across Australian health organizations has identified how these individuals can accidentally weaken organizational resilience.
Research suggests that the paradox operates through three distinct yet interconnected mechanisms. Specifically, knowledge concentration occurs when critical expertise stays with the individual rather than being integrated into institutional systems. Furthermore, dependency creation happens when organizations rely exclusively on champions for quality assurance and daily problem-solving. Finally, the champion's success often prevents system capacity building by concealing the organization's underlying need for structural improvements. Therefore, the effective champion may unintentionally become a single point of failure.
To overcome the champion paradox, healthcare administrators should view champions as transitional resources rather than permanent drivers of quality. In addition, organizations must prioritize the development of collective capacity and standardized protocols. Moreover, sustainability assessments should evaluate whether a program can function without its primary advocate. By shifting focus toward system-dependent implementation strategies, institutions can better ensure the longevity of their clinical innovations.
A champion is an individual within an organization who shows a strong commitment to promoting a specific innovation or practice through their expertise and social influence.
Organizations can avoid this paradox by designing implementation strategies that focus on building collective skills and institutionalizing processes rather than relying solely on individual leadership.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Refer to the latest local and national guidelines for clinical practice.
References
Stark H et al. The champion paradox: the dual effects of implementation champions on the sustainment of evidence-based practices. Implement Sci Commun. 2026 May 14. doi: 10.1186/s43058-026-00959-2. PMID: 42135818.
Nilsen P. Making sense of implementation theories, models and frameworks. Implement Sci. 2015 Apr 21;10:53. doi: 10.1186/s13012-015-0242-0. PMID: 25895742.
Proctor E et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and next steps. Adm Policy Ment Health. 2011 Mar;38(2):65-76. doi: 10.1007/s10488-010-0319-7. PMID: 20957426.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study defines the 'champion paradox,' showing how individuals who drive program success may inadvertently weaken organizational systems over the long term...
5 months ago

Co-administering antiseizure medications and DOACs frequently causes pharmacokinetic interactions, subtherapeutic drug levels, and thromboembolic failures. This review highlights enzyme induction risks, unpredictable outcomes with levetiracetam, and the vital role of therapeutic drug monitoring.
Today

Demanding exhaustive hormonal profiling can inadvertently discourage clinical studies involving females. Methodological standards must align with the specific scientific question to expand, not restrict, equitable evidence for women.
Today

An elderly man with partially repaired Tetralogy of Fallot presented with STEMI caused by coronary embolism rather than atherosclerosis. Successful treatment with sustained mechanical aspiration thrombectomy underscores the vital need for high clinical vigilance in adult congenital heart disease.
Today

A comparative review of tension band wiring and intramedullary screw fixation in thumb metacarpophalangeal arthrodesis, evaluating union rates, hardware complications, and clinical outcomes.
Today

Following regulatory scrutiny from FSSAI regarding promotional representations and lean muscle preservation claims, Dr. Reddy's Laboratories and Nestlé Health Science are currently reviewing the branding and marketing strategy for their joint nutritional supplement Celevida GLP+.
Today